Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years

NCT00161967 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
November 30, 2008
Enrollment
375 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, tick-borne